Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 2
1991 2
1992 2
1993 1
1994 8
1995 4
1996 9
1997 3
1998 1
1999 5
2000 6
2001 5
2002 3
2003 5
2004 5
2005 4
2006 7
2007 5
2008 3
2009 4
2010 5
2011 8
2012 14
2013 17
2014 2
2015 3
2016 6
2017 5
2018 4
2019 2
2020 9
2021 6
2022 8
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Results by year

Filters applied: . Clear all
Page 1
Reply by Authors.
Douglawi A, Calaway A, Tachibana I, Panizzutti Barboza M, Speir R, Masterson T, Adra N, Foster R, Einhorn L, Cary C. Douglawi A, et al. Among authors: tachibana i. J Urol. 2020 Jul;204(1):102-103. doi: 10.1097/JU.0000000000000792.03. Epub 2020 Apr 24. J Urol. 2020. PMID: 32330400 No abstract available.
Robotic Sacral Colpopexy.
Powell CR, Tachibana I, Eckrich B, Rothenberg J, Hathaway J. Powell CR, et al. Among authors: tachibana i. J Endourol. 2018 May;32(S1):S111-S116. doi: 10.1089/end.2018.0054. J Endourol. 2018. PMID: 29774820
Adiponectin: a novel link between adipocytes and COPD.
Takeda Y, Nakanishi K, Tachibana I, Kumanogoh A. Takeda Y, et al. Among authors: tachibana i. Vitam Horm. 2012;90:419-35. doi: 10.1016/B978-0-12-398313-8.00016-6. Vitam Horm. 2012. PMID: 23017725 Review.
Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer.
Antonelli L, Ardizzone D, Tachibana I, Adra N, Cary C, Hugar L, Sexton WJ, Bagrodia A, Mego M, Daneshmand S, Nicolai N, Nazzani S, Giannatempo P, Franza A, Heidenreich A, Paffenholz P, Saoud R, Eggener S, Ho M, Oswald N, Olson K, Tryakin A, Fedyanin M, Naoun N, Javaud C, Cazzaniga W, Nicol D, Gerdtsson A, Tandstad T, Fizazi K, Fankhauser CD; EAU-YAU Penile and Testis Cancer Working Group. Antonelli L, et al. Among authors: tachibana i. J Clin Oncol. 2023 Dec 1;41(34):5296-5305. doi: 10.1200/JCO.23.00443. Epub 2023 Sep 1. J Clin Oncol. 2023. PMID: 37656935
Efficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial Carcinoma.
Labbate C, Woldu S, Murray K, Rose K, Sexton W, Tachibana I, Kaimakliotis H, Jacob J, Dickstein R, Linehan J, Nieder A, Bjurlin M, Humphreys M, Ghodoussipour S, Quek M, O'Donnell M, Eisner B, Feldman A, Lotan Y, Matin SF. Labbate C, et al. Among authors: tachibana i. J Urol. 2023 May;209(5):872-881. doi: 10.1097/JU.0000000000003185. Epub 2023 Jan 19. J Urol. 2023. PMID: 36657029
First analysis of the safety and efficacy of UGN-101 in the treatment of ureteral tumors.
Jacob JM, Woldu SL, Linehan J, Labbate C, Rose KM, Sexton WJ, Tachibana I, Kaimakliotis H, Nieder A, Bjurlin MA, Humphreys M, Ghodoussipour SB, Quek ML, Johnson B, O'Donnell M, Eisner BH, Feldman AS, Murray KS, Matin SF, Lotan Y, Dickstein RJ. Jacob JM, et al. Among authors: tachibana i. Urol Oncol. 2024 Jan;42(1):20.e17-20.e23. doi: 10.1016/j.urolonc.2023.07.004. Epub 2023 Jul 28. Urol Oncol. 2024. PMID: 37517898
The ablative effect of mitomycin reverse thermal gel: Expanding the role for nephron preservation therapy in low grade upper tract urothelial carcinoma.
Kaimakliotis HZ, Tachibana I, Woldu S, Labbate C, Jacob J, Murray K, Rose K, Sexton W, Dickstein R, Linehan J, Nieder A, Bjurlin M, Humphreys M, Ghodoussipour S, Quek M, O'Donnell M, Eisner BH, Matin SF, Lotan Y, Feldman AS. Kaimakliotis HZ, et al. Among authors: tachibana i. Urol Oncol. 2023 Sep;41(9):387.e1-387.e7. doi: 10.1016/j.urolonc.2023.04.010. Epub 2023 May 26. Urol Oncol. 2023. PMID: 37246135
170 results